Page 62 - MI-2-1
P. 62

Microbes & Immunity                                       ABO blood type and cancer risk: A complex relationship



            31.  Zhang  S, Zhang HS,  Cordon-Cardo  C,  et al.  Selection   Perspectives. Switzerland: Frontiers Media; 2020.
               of tumor antigens as targets for immune attack using   doi:10.3389/fphar.2020.00480
               immunohistochemistry: II. Blood group-related antigens.
               Int J Cancer. 1997;73(1):50-56.                 43.  Bronte F, Manu KA, Giunta EF. Reviews in Gastrointestinal
                                                                  Cancers. Switzerland: Frontiers Media; 2023.
               doi: 10.1002/(sici)1097-0215(19970926)73:1<50:aid-ijc9>3.0.co;2-0
                                                                  doi:10.3389/fonc.2023.1252665
            32.  Capuzzo E, Bonfanti C, Frattini F,  et al. The relationship
               between ABO blood group and cardiovascular disease:   44.  Shad KF. Blood Groups: More than Inheritance of Antigenic
               Results  from  the  Cardiorisk  program.  Ann Transl Med.   Substances. Germany: BoD – Books on Demand; 2022.
               2016;4(10):189.                                    doi: 10.5772/intechopen.94700
               doi: 10.21037/atm.2016.03.58                    45.  Mao Y, Yang W, Qi Q, et al. Blood groups A and AB are
            33.  Franchini M, Frattini F, Crestani S, Bonfanti C, Lippi G. von   associated with increased gastric cancer risk: Evidence from
               Willebrand factor and cancer: A renewed interest. Thromb   a large genetic study and systematic review. BMC Cancer.
               Res. 2013;131(4):290-292.                          2019;19(1):164.
               doi: 10.1016/j.thromres.2013.01.015                doi: 10.1186/s12885-019-5355-4
            34.  Jenkins PV, O’Donnell JS. ABO blood group determines   46.  Yu H, Xu N, Li ZK, et al. Association of ABO blood groups
               plasma  von  Willebrand  factor  levels:  A  biologic  function   and risk of gastric cancer. Scand J Surg. 2020;109(4):309-313.
               after all? Transfusion. 2006;46(10):1836-1844.     doi: 10.1177/1457496919863886
               doi: 10.1111/j.1537-2995.2006.00975.x           47.  Huang JY, Wang R, Gao YT, Yuan JM. ABO blood type and
            35.  Grivennikov SI, Greten FR, Karin M. Immunity,    the risk of cancer  -  Findings from the Shanghai Cohort
               inflammation, and cancer. Cell. 2010;140(6):883-899.  Study. PLoS One. 2017;12(9):e0184295.
               doi: 10.1016/j.cell.2010.01.025                    doi: 10.1371/journal.pone.0184295
            36.  Melzer D, Perry JRB, Hernandez D, et al. A genome-wide   48.  Liu Y, Chen S, Shen W, Qu X, Li S, Shi Y. Construction and
               association study identifies protein quantitative trait loci   validation of a gastric cancer diagnostic model based on blood
               (pQTLs). PLoS Genet. 2008;4(5):e1000072.           groups and tumor markers. J Cancer. 2024;15(3):729-736.
               doi: 10.1371/journal.pgen.1000072                  doi: 10.7150/jca.88190
            37.  Greenwell P. Blood group antigens: Molecules seeking a   49.  Sun W, Wen CP, Lin J, et al. ABO blood types and cancer
               function? Glycoconj J. 1997;14(2):159-173.         risk--a cohort study of 339,432 subjects in Taiwan. Cancer
                                                                  Epidemiol. 2015;39(2):150-156.
               doi: 10.1023/a:1018581503164
                                                                  doi: 10.1016/j.canep.2014.12.006
            38.  Kaffenberger  SD,  Morgan  TM,  Stratton  KL,  et al.  ABO
               blood group is a predictor of survival in patients undergoing   50.  Tanaka Y, Kumagi T, Terao T, et al. ABO blood type and
               surgery for renal cell carcinoma.  BJU Int. 2012;110(11 Pt   the long-term outcomes of pancreatic cancer. Intern Med.
               B):E641-E646.                                      2020;59(6):761-768.
                                                                  doi: 10.2169/internalmedicine.3748-19
               doi: 10.1111/j.1464-410X.2012.11366.x
                                                               51.  Nakao  M,  Matsuo  K,  Hosono  S,  et al.  ABO  blood  group
            39.  Eibl G, Edderkaoui M. Risk Factors for Pancreatic Cancer:
               Underlying Mechanisms and Potential Targets. Switzerland:   alleles and the risk of pancreatic cancer in a Japanese
               Frontiers Media; 2015.                             population. Cancer Sci. 2011;102(5):1076-1080.
                                                                  doi: 10.1111/j.1349-7006.2011.01907.x
               doi: 10.3389/fphys.2014.00490
                                                               52.  Greer JB, Yazer MH, Raval JS, Barmada MM, Brand RE,
            40.  Neoptolemos JP, Urrutia RA, Abbruzzese J, Büchler MW.
               Pancreatic Cancer. Germany: Springer Science and Business   Whitcomb DC. Significant association between ABO
               Media; 2010.                                       blood group and pancreatic cancer. World J Gastroenterol.
                                                                  2010;16(44):5588-5591.
               doi:10.1007/978-1-4939-7193-0
                                                                  doi: 10.3748/wjg.v16.i44.5588
            41.  Bahia D, Satoskar A, Dussurget O. Cell Signaling in Host–
               Pathogen Interactions: The Host Point of View. Switzerland:   53.  Vedie AL, Laouali N, Gelot A, Severi G, Boutron-
               Frontiers Media; 2018.                             Ruault  MC, Rebours V. Childhood and adulthood passive
                                                                  and active smoking, and the ABO group as risk factors for
               doi:10.3389/fimmu.2018.00221                       pancreatic cancer in women.  United Eur Gastroenterol J.
                                                                  2024;12(4):440-450.
            42.  Zusso M, Moro S, Giusti P, Stokes L. Neuroinflammation and
               Its Resolution: From Molecular Mechanisms to Therapeutic      doi: 10.1002/ueg2.12487


            Volume 2 Issue 1 (2025)                         54                               doi: 10.36922/mi.3267
   57   58   59   60   61   62   63   64   65   66   67